GlassScriptPhysician profile
Steven B Richlin
NPI 1134100878
$13,130.49
in general payments reported to CMS, 2019-2025
26 companies · $5,095 in 2025
The $5,095 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,695 · 2020: $1,172 · 2021: $574 · 2022: $1,006 · 2023: $1,043 · 2024: $545 · 2025: $5,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $1,657 · Entertainment: $26.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $1,656.58 |
| Entertainment | $26.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $8,578.94 | 2019-2025 | Dailies Total1, Precision 1, Air Optix Color |
| Johnson & Johnson Vision Care, INC. | $1,660.24 | 2019-2024 | Acuvue |
| Abb Con-Cise Optical Group LLC | $515.74 | 2019-2022 | |
| Coopervision INC. | $486.26 | 2019-2025 | Onefit Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $339.11 | 2019-2021 | |
| Optos, INC. | $155.08 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $142.09 | 2019 | |
| Bausch & Lomb Americas INC. | $134.21 | 2024 | Infuse |
| Aerie Pharmaceuticals, INC. | $127.33 | 2019 | |
| Eyevance Pharmaceuticals LLC | $123.30 | 2020-2023 | Flarex |
| Sight Sciences, INC. | $114.83 | 2019 | |
| Abbvie INC. | $109.91 | 2022-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $106.50 | 2019 | |
| Optovue, INC. | $95.82 | 2019 | |
| Allergan, INC. | $67.53 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $54.23 | 2020 | |
| Lkc Technologies, INC. | $47.72 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $47.40 | 2020-2024 | |
| Novartis Pharmaceuticals Corporation | $44.84 | 2019-2020 | |
| Dompe US, INC. | $44.55 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $31.05 | 2024 | Xdemvy |
| Visioneering Technologies, INC. | $25.59 | 2019 | |
| Horizon Therapeutics Plc | $23.43 | 2023 | Tepezza |
| Oyster Point Pharma, INC. | $20.38 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Biotissue Holdings INC. | $15.01 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Richlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.